BOSTON, USA and UPPSALA, Sweden, Sept. 26, 2024 Precision for Medicine, a leading global precision medicine clinical research organization, is pleased to announce a strategic partnership with Navinci. This collaboration will integrate Navinci’s advanced in situ proximity ligation assay kits into Precision for Medicine’s comprehensive service offerings, empowering researchers with innovative tools to drive deeper insights into protein functions and interactions.
Navinci’s in situ proximity ligation assays (isPLA) are used to detect and quantify protein-protein interactions, post-translational modifications, and single protein localization with unparalleled sensitivity and specificity.
Amanda Woodrooffe, PhD, SVP, UK Lab Operations, commented, “Partnering with Navinci allows us to expand our biomarker capabilities. Their innovative in situ proximity ligation assays will enable us to offer our clients more precise and comprehensive data on protein interactions and modifications. This collaboration underscores our commitment to providing cutting-edge solutions that drive advancements in drug development and personalized medicine.”
“We are very excited to work with Precision for Medicine to bring our assays for in situ protein-protein interaction and post-translational modification detection, as well as that of low abundance and otherwise hard-to-detect proteins to their biotech and pharma customers. This will enrich biopharma’s biomarker and MOA analysis and diagnostics development by providing functionality as well as expression in spatial protein interrogation in tissues and cells,” said Subham Basu, Chief Business Officer at Navinci.
About Precision for Medicine
Precision for Medicine is a leading global precision medicine clinical research organization, offering a breadth of solutions including biospecimens, specialty and central lab services, full-service clinical trials, and advanced data intelligence services. With numerous technologies, over 2,000 professionals and experts, and 35 offices worldwide, Precision for Medicine is dedicated to advancing life-changing treatments globally.
For more information, visit Precision for Medicine.
About Navinci
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
For more information, visit Navinci.